Good news for chronic migraine

Journal of Headache and Pain

Volumn 7, Issue 4, 2006, Pages 169-171

  Pascual, Julio ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CENTRAL STIMULANT AGENT; ERGOT DERIVATIVE; GABAPENTIN; OPIATE; PLACEBO; TOPIRAMATE; VALPROIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; NOTE; PAIN ASSESSMENT; PRIORITY JOURNAL; TRANSFORMED MIGRAINE; TREATMENT RESPONSE; CHRONIC DISEASE; DRUG COMBINATION; MIGRAINE; PATHOPHYSIOLOGY; STATISTICS;

ANALGESICS; ANTICONVULSANTS; BOTULINUM TOXIN TYPE A; CHRONIC DISEASE; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; FRUCTOSE; HUMANS; MIGRAINE DISORDERS;

EID: 33846822003     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-006-0311-5     Document Type: Note

References (14)

1. Castillo J, Muñoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:497-506
2. Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily or near daily headaches: Proposed revisions to the IHS classification. Headache 34:1-7
3. Peres MFP, Mercante JPP, Tanuri FC, Nunes M, Zukerman E (2006) Chronic migraine prevention with topiramate. J Headache Pain 7:169-171
4. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796-803
5. Pascual J, Sánchez del Río M, Mateos V et al (2004) Topiramate for patients with refractory migraine: An observational, multicenter study in Spain. Neurología 18:364-367
6. Rothrock JF, Parada VA, Drinkard R, Zweifler RM, Key KF (2005) Predictors of a negative response to topiramate therapy in patients with chronic migraine. Headache 45:932-935
7. Borzy JC, Koch TK, Schimschock JR (2005) Effectiveness of topiramate in the treatment of pediatric chronic headache. Pediatr Neurol 33:314-316
8. Bartolini M, Silvestrini M, Taffi R et al (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 28:277-279
9. Freitag FG, Diamond S, Diamond M, Urban G (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41:271-278
10. Spira PJ, Beran RG, for the Australian Gabapentin Chronic Daily Headache Group (2003) A randomized, placebocontrolled study. Neurology 61:1753-1759
11. Silvestrini M, Bartolini M, Coccia M et al (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23:820-824
12. Diener HC, Goadsby PJ, Bussone G et al (2006) Assessing the efficacy and safety of topiramate for the prevention of chronic migraine. J Headache Pain 7[Suppl 1]:45
13. Dodick D, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study. Headache 45:315-324
14. Matharu MS, Bartsch T, Ward N et al (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain 127:220-230